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Alternative splicing and mRNA editing are known to contribute to transcriptome diversity. Although alternative splicing
is pervasive and contributes to a variety of pathologies, including cancer, the genetic context for individual differences in
isoform usage is still evolving. Similarly, although mRNA editing is ubiquitous and associated with important biological
processes such as intracellular viral replication and cancer development, individual variations in mRNA editing and the
genetic transmissibility of mRNA editing are equivocal. Here, we have used linkage analysis to show that both mRNA
editing and alternative splicing are regulated by the macrophage genetic background and environmental cues. We show
that distinct loci, potentially harboring variable splice factors, regulate the splicing of multiple transcripts. Additionally,
we show that individual genetic variability at the Apobec1 locus results in differential rates of C-to-U(T) editing in murine
macrophages; with mouse strains expressing mostly a truncated alternative transcript isoform of Apobec1 exhibiting lower
rates of editing. As a proof of concept, we have used linkage analysis to identify 36 high-confidence novel edited sites.
These results provide a novel and complementary method that can be used to identify C-to-U editing sites in individuals
segregating at specific loci and show that, beyond DNA sequence and structural changes, differential isoform usage and
mRNA editing can contribute to intra-species genomic and phenotypic diversity.
[Supplemental material is available for this article.]
Splicing is an obligatory step in the processing of both coding
and noncoding RNA precursors (pre-RNA) to mature RNA, and
is executed by a ribonucleoprotein megaparticle known as the
spliceosome. Even though the sequential assembly of the
spliceosome (Kornblihtt et al. 2013) can occur around any
splice site that consists of consensus sequences recognized by
the spliceosomal components, splice sites that conform better
to a consensus sequence are strongly recognized and favored by the
spliceosome complex. Besides the consensus sequences, the selec-
tion of optimal splice sites is regulated, in part, by a minimal set of
conserved cis-acting GU and AG sequences at the 59 and 39 splice
sites, respectively (Wang et al. 2008), and sequence elements known
as intronic/exonic splicing enhancers and silencers (Wang and
Burge 2008; Lee et al. 2012). As such, genetic variation at the splice
site, in the consensus sequences, or in the intronic/exonic en-
hancers and repressors may lead to alternative splicing (AS), result-
ing in alternative transcripts and protein isoforms from a single
gene. AS is known to affect biological processes such as cell death,
pluripotency (Irimia and Blencowe 2012; Han et al. 2013), and tu-
mor progression (Venables et al. 2009), and can also contribute to
phenotypic diversity within species. Indeed, independent studies
have recently revealed that AS may supersede variable gene ex-
pression in determining human phenotypic differences (Heinzen
et al. 2008). For example, individual differences in the splicing of
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) affect
the efficacy of statins (Medina andKrauss 2009),while induced exon
skipping in the dystrophin gene is being explored for Duchenne
muscle dystrophy therapy (Mitrpant et al. 2009). Therefore, the
identification of genetic variants that modulate splicing may
result in a better understanding of the genetic basis for individual
differences in susceptibility to disease.
In addition to AS, biological systems have evolved additional
mechanisms that alter the fidelity of the information coded in
DNA and RNAs, thereby increasing genome diversity. One such
mechanism is DNA and RNA editing (Gray 2012). Since its dis-
covery in trypanosomatids (Benne et al. 1986), editing has been
found in Drosophila (Rodriguez et al. 2012), humans (Fritz et al.
2013), and mice (Rosenberg et al. 2011). Editing is generally cata-
lyzed by cytidine deaminase or adenosine deaminase enzymes
(Hamilton et al. 2010). Broadly, the cytidine deaminase family of
enzymes includes the activation-induced cytidine deaminase (AID
or AICDA) and the apolipoprotein B mRNA editing enzyme, cat-
alytic polypeptides (APOBECs). Even though related, AICDA has
been shown to primarily deaminate cytidine to thymidine in DNA
and is important in antibody diversification processes (Fritz et al.
2013), while APOBECs can edit both DNA and RNA, converting
cytidine to uridine in RNA or to thymidine in DNA. The APOBEC
deaminase family includes APOBEC1, APOBEC2, APOBEC3, and
APOBEC4, with APOBEC3 reported to have various isoforms in
humans (A3A, A3B, A3C, A3D, A3F, A3G, and A3H). No biological
function for APOBEC2 and 4 has been reported, while APOBEC1
and 3 have been implicated in cancer development (Fritz et al.
2013; Roberts et al. 2013) and inhibition of viral replication
(Niewiadomska and Yu 2009; Krisko et al. 2013). However, the
most common form of editing in higher eukaryotes is catalyzed by
the adenosine deaminase acting on RNA (ADAR) enzyme and in-
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volves the deamination of adenosine to inosine (Athanasiadis et al.
2004; Kim et al. 2004; Levanon et al. 2004; Li et al. 2011), which is
then recognized as guanosine by the RNA translation machinery.
The mammalian genome encodes three Adar genes (Adar, Adarb1,
and Adarb2), whose proteins share a common variable N-terminal
mRNA binding and a C-terminal catalytic deaminase domain
(Melcher et al. 1996; Valente and Nishikura 2005). Even though
both ADAR and ADARB1 are catalytically active (Nishikura 2010),
ADAR is the best characterized, while the function of ADARB2 is
unclear (Chen et al. 2000). Like AICDA and APOBEC, ADAR-cata-
lyzed editing has been implicated in a variety of biological processes,
including AS (Solomon et al. 2013), viral replication (Doria et al.
2009), and immune development (Hartner et al. 2009). Similarly to
mRNA splicing, the determination ofwhich cytidine or adenosine to
deaminate is guided by consensus sequences, proximal to the edited
nucleotide, which are then recognized by themRNA bindingmotifs
in the editing enzymes (Anant and Davidson 2000; Rosenberg et al.
2011; Bahn et al. 2012). Therefore, like AS, genetic variation in the
editingmooring sequence or in themRNAbinding site of the editing
enzyme may affect the rate of editing between and within species.
Even though mRNA splicing and editing have been impli-
cated in a variety of biological processes and potentially contribute
to phenotypic diversity within species, individual differences in,
and the genetic transmissibility of, mRNA splicing and editing are
still ambiguous. Individually or together, AS and mRNA editing
contribute to define macrophage biology and are important in the
response to various stimuli. For instance, macrophage activation
with endotoxin or interferon gamma (IFNG) has previously been
shown to result in increased ADAR editing activity (Rabinovici
et al. 2001), while APOBEC3A expression has been implicated in
the differential resistance ofmonocytes andmacrophages to HIV-1
(Peng et al. 2007). Here, we hypothesized that the macrophage
genetic background and environmental milieu modulate the rate
of mRNA splicing and editing. To test this, we investigated isoform
usage and the rate of mRNA editing in bone marrow–derived
macrophages (BMDMs) obtained from the laboratory inbred A/J
and C57BL/6J mice and from AXB and BXA recombinant inbred
(RI) mouse strains before and after stimulation with a variety of
stimuli, including IFNG and the intracellular pathogenToxoplasma
gondii. We show that both isoform usage and the rate of mRNA
editing are quantitative traits influenced by the macrophage ge-
netic background and environment.
Results
Macrophage genetic background and environmental milieu
modulate isoform usage
The widely used laboratory inbred A/J (AJ) and C57BL/6J (B6) mice
display variable susceptibility to a variety of infectious agents—
such as Staphylococcus aureus, T. gondii, and Trypanosoma cruzi
(McLeod et al. 1989; Parekh et al. 1998; Ahn et al. 2010; Silva et al.
2013)—and inflammatory pathologies such as atherosclerosis,
obesity, and type 2 diabetes (Paigen et al. 1985; Surwit et al. 1988;
Surwit et al. 1995). These phenotypic differences often replicate in
the AXB/BXA RI mice, derived from an initial reciprocal cross of AJ
and B6 mice followed by multiple rounds ($20) of inbreeding
(Nesbitt and Skamene 1984;Marshall et al. 1992). Importantly, the
RI mice have stable genomes that are homozygous for virtually
every polymorphic parental allele and have been useful for map-
ping AJ and B6 genetic differences (McLeod et al. 1989; Matesic
et al. 1999; Boyle and Gill 2001). Therefore, to investigate how the
genetic background and stimulation conditions modulate isoform
usage in macrophages, we performed high-throughput RNA-
sequencing (RNA-seq) on BMDMs obtained from female AJ, B6, and
26 AXB/BXAmice (28 samples in total) before and after stimulation
with IFNG/tumor necrosis factor alpha (TNF), inflammatory cyto-
kines important in the immune response against most intracellular
pathogens, or CpG, a synthetic double-stranded DNA that activates
TLR9, or infection with T. gondii, an obligate intracellular apicom-
plexan parasite. Using Illumina HiSeq 2000, we generated at least
100 million paired-end reads from each of the 28 samples in each
macrophage condition, except for the IFNG/TNF-stimulated mac-
rophages that were sequenced on a single end.
Initially, we aligned the RNA-seq reads to themouse reference
genome (mm9, NCBI build 37.2 downloaded from Illumina
iGenomes; http://cufflinks.cbcb.umd.edu/igenomes.html) using
TopHat (Trapnell et al. 2009), which automatically integrates
Bowtie (Langmead et al. 2009). However, because sequence poly-
morphisms between AJ and B6 can skew read mapping toward the
reference allele, wemade a synthetic reference genome inwhich all
the polymorphic nucleotides between AJ and B6were converted to
a neutral nucleotide (Degner et al. 2009). This way, if a poly-
morphism initially affected themapping of reads obtained fromAJ
alleles to the reference (B6) genome, it would now affect reads from
the B6 alleles as well, thereby eliminating read mapping bias. On
average, 70% of reads in the individual samples uniquely mapped
to the synthetic genome, which was on average 1% less than the
number of reads mapped to the iGenome. Henceforth, unless
otherwise stated, all the RNA-seq data used herein are based on
alignment to the synthetic genome.
Because the expression of individual isoforms may be linked
to the expression level of the parent transcript and not splicing per
se, overall isoform expression levelsmay not be a goodmeasure for
differential isoform usage. Therefore, tomeasure isoform usage, we
computed the ratio of reads supporting each splicing event, de-
scribed as percent-spliced-in (PSI), using the mixture-of-isoforms
(MISO) program (Katz et al. 2010) and a compendium of exon-
centric and 39 UTR alternative events (Wang et al. 2008; Hoque
et al. 2013). MISO uses a Bayesian logic to model the generative
process by which RNA-seq reads are produced from isoforms and
generates confidence intervals (CIs) for estimates of exon and
isoform abundance and a Bayes factor (BF), which can be used to
estimate differential isoform usage between samples (for a detailed
description of MISO, see Katz et al. 2010). Thus, treating each
macrophage condition (nonstimulated, IFNG/TNF-stimulated,
CpG-stimulated, and Toxoplasma-infected) as an independent co-
hort, we calculated the PSI values for each splicing event in each of
the 28 samples. Of the 16,974 annotated exon-centric and 39 UTR
alternative events (Wang et al. 2008; Hoque et al. 2013), excluding
alternative first and last exons, 9954, 9198, 10,604, and 9963
events had a PSI $ 0.2 (i.e., supported by at least 20% of the total
reads originating from the constitutive and alternative exons) in at
least five mice in the nonstimulated, IFNG/TNF-stimulated, CpG-
stimulated, and Toxoplasma-infected macrophages, respectively.
Out of the 9036 nonredundant genes with annotated exon-centric
and 39 UTR alternative events, 6646 genes had PSI $ 0.2, in more
than five mice, in at least one macrophage condition.
Because the RI mice are homozygous at each polymorphic
parental allele, and assuming there is no epistasis, we reasoned that
if the macrophage genetic background modulates mRNA splicing,
then isoformusage should vary in the RImice and their progenitors.
To investigate this, we used B6 as a reference and calculated the BF
for each splicing event in each sample using MISO. To identify
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isoforms that are differentially used among mouse strains, we re-
quired that an event must have a BF $ 5 (i.e., the isoform is five
times more likely to be differentially used) in at least five mice. The
BF calculations and the filtering steps were performed separately for
each macrophage condition. The requirement for five samples was
due to the observation that at each of the 934 unique AXB/BXA
genetic markers (Sampson et al. 1998; Williams et al. 2001), at
least four RI mice carry the AJ or the B6 allele. In the end, we ob-
served 2376, 961, 3067, and 787 events, from 1870, 821, 2309, and
678 nonredundant transcripts, in the nonstimulated, IFNG/TNF-
stimulated, CpG-stimulated, and Toxoplasma-infected BMDMs, re-
spectively, for which the relative isoform usage was determined by
the macrophage genetic background (Supplemental Table 1A–D).
This translates to a total of 4677 unique alternative events from all
the macrophage conditions, of which 1719 were present in at least
two macrophage conditions (Supplemental Table 1E). Included in
this category were interleukin 3 receptor alpha (Il3ra), Apobec3, and
C-type lectin domain family 7, member a (Clec7a) (also known as
dectin-1) transcripts (Fig. 1), which independent studies have
shown to be differentially spliced and to contribute to pheno-
Figure 1. Isoform usage varies between laboratory mouse strains. We observed differential isoform usage (reflected by the different PSI values) of
Apobec3 (A), Clec7a (B), and Il3ra (C ) between the different mouse strains. Shown are the percent-splice-in (PSI, c) for the longest isoform for each gene,
and the lower and upper 95% confidence intervals (CIs) (in parentheses). Also shown is the total number of reads supporting each splice junction. Due to
the low, almost absent, expression of the alternative Il3ra isoform in the AJ, which is consistent with a previous observation (Ichihara et al. 1995), there are
no reads supporting the alternative splice junction, which is also the reason for the large CI. The alternative isoforms for both Apobec3 and Clec7a are due to
a skipped exon, while the Ilr3a alternative isoform is due to an alternative 39 splice site (alternative acceptor).
Genetics of mRNA splicing and C-to-U editing
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typic diversity between several mouse strains, including AJ and
B6 (Ichihara et al. 1995; Jimenez-A et al. 2008; Li et al. 2012).
Besides genetic variants, splicing can also be modulated by
the physiological state of the cell, e.g., cancerous versus healthy
cells or stimulated versus nonstimulated cells. If a splicing event is
modulated by cellular homeostasis, irrespective of themacrophage
genetic background, then we do not expect its isoform usage to
vary among the mouse strains. Therefore, to investigate stimulus-
induced differential isoform usage, we calculated the BF for each
splicing event between matched mouse strains in the different
macrophage conditions, e.g., to investigate differential usage of
event ‘‘A’’ in the nonstimulated versus infected BMDM, we calcu-
lated the BF for event ‘‘A’’ inmouse strain ‘‘X’’ in the nonstimulated
condition relative to event ‘‘A’’ in mouse strain ‘‘X’’ in the infected
condition. In total, we observed 594 differentially used (BF $ 5 in
at least five samples for each pairwise comparison) isoforms from
all the possible pairwise macrophage condition comparisons
(Supplemental Table 1F). For example, even though Samhd1 AS, in
which the 14th exon is skipped, did not vary between the mouse
strains, the IFNG/TNF-stimulated macrophages express more of
the primary isoform, while Toxoplasma-infected macrophages ex-
press mostly the alternative isoform (Fig. 2). SAMHD1 is known to
restrict intracellular HIV-1 virus replication by depleting cellular
dNTP levels. Interestingly, the primary isoform is known to be
stable and able to degrade dNTPs, while the alternative isoform is
unstable and metabolically inactive (Welbourn et al. 2012).
Thus, both the genetic background and the environmental
milieu determine isoform usage in murine macrophages.
Distinct loci modulate isoform usage in murine macrophages
The results described above implicate the macrophage genetic
background in mRNA splicing without revealing the dynamics of
isoform usage in murine macrophages. Therefore, to identify the
genetic factors that modulate differential isoform usage, we used
the PSI values obtained from the RI mice as quantitative traits, and
the corresponding genetic map (containing 934 informative ge-
netic markers) in a genome-wide scan to identify the genomic loci
that modulate mRNA splicing (splicing quantitative trait loci
[sQTL]) using R/qtl (Broman et al. 2003). To correct the QTL
P-value of individual isoforms for multiple testing at the 934 ge-
netic markers, we used 1000 permutation tests linked across phe-
notypes, i.e., permutation on the rows of the phenotype matrix
relative to the row of the genotype matrix (Burrage et al. 2010) in
R/qtl. Next, to correct for testing of multiple isoforms, we calcu-
lated the corresponding false-discovery rate (FDR) using the qvalue
package (Storey and Tibshirani 2003) and used FDR# 10% to select
significant sQTL. As in the previous section, all the linkage analysis
and subsequent filtering steps were performed separately for each
macrophage condition. In the end, we identified 205, 285, 395,
and 268 significant sQTL in the nonstimulated, IFNG/TNF-
stimulated, CpG-stimulated, and infected macrophages, respec-
tively (Supplemental Table 1G–J). Therefore, in agreement with
previous studies (Ichihara et al. 1995; Jimenez-A et al. 2008), we
have shown, using Il3ra, Apobec3, and Clec7a as examples, that
isoform usage is modulated by the mouse genetic background
(Fig. 3A). Similarly, although not significantly associated with
a genomic region, when averaged based on the genotype at the
suggestive sQTL, the PSI for Samhd1, which is modulated entirely
by the macrophage stimulation condition, was significantly
variable between the relevant conditions (Fig. 3B). However, due
to the mosaic introgression of AJ and B6 alleles in the RI genome,
the complex regulation of mRNA splicing, and the few number
of mice available in this RI line, linkage was not observed for
all the splicing events modulated by the macrophage genetic
background.
Figure 2. Stimulus-specific differential splicing. Even though isoform usage for Samhd1 was the same between the strains, we observed stimulus-
specific differential isoform usage for Samhd1 between IFNG/TNF-stimulated and infected BMDM. The Samhd1 event is due to the skipping of the 14th
exon, and the alternative isoform is known to be metabolically unstable and catalytically (dNTPase activity) inactive. Shown are the PSI (c) for the longest
isoform for each strain, and the lower and upper 95% CIs (in parentheses).
Hassan et al.
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AS can be due to variations at the splice site (cis) or to poly-
morphic or differentially expressed splice factors, enhancers,
and repressors (trans) (Wang and Burge 2008; Lee et al. 2012;
Zaphiropoulos 2012). Therefore, based on the distance from the
corresponding splice site, the sQTL can be categorized as cis or
trans. Thus, we computed sQTL distance from the relevant splice
site, and using a genomic window of 10 Mb, we designated each
sQTL as cis (#10 Mb from splice site) or trans (>10 Mb from splice
site) (Table 1; Supplemental Table 1G–J). Generally, cis-sQTL are
expected to be due to structural or sequence variations in the
vicinity of the splice site (Lee et al. 2012). Therefore, we inspected
the significant sQTL for single nucleotide polymorphisms (SNPs)
proximal to the splice site (#250 bp from splice site) and observed
that, unlike the trans-sQTL, significantly (Student’s t-test, P < 0.05)
more cis-sQTL had SNPs close to the splice site (Table 1; Supple-
mental Table 1G–J). A single splice factor, enhancer or repressor, can
modulate the splicing of several events. In linkage analysis, we ex-
pect the sQTL for such events to colocalize to the same genomic
region (trans-sQTL hotspots or trans-band), proximal to the com-
mon splicing regulator. Indeed we observed such trans-sQTL
hotspots in the current study. For example, we observed a trans-
band on chromosome 5 for the significant events in the IFNG/
TNF-stimulatedmacrophages (Fig. 4). However, it is plausible that
sQTL can colocalize by chance alone. Therefore, to eliminate this
possibility, we used Bonferroni-corrected P-values and Poisson
distribution to compute the number of trans-sQTL that need to
colocalize in a 10-Mb genomic window to constitute a trans-band
and found six, seven, six, and five for the nonstimulated, IFNG/
TNF-stimulated, CpG-stimulated, and infected macrophages, re-
spectively. Subsequently, using these cutoffs, we identified three,
four, four, and three trans-sQTL hotspots in the nonstimulated,
IFNG/TNF-stimulated, CpG-stimulated, and infected macrophages,
respectively (Supplemental Table 1G–J) that were functionally
enriched for a variety of biological processes, including T-cell dif-
ferentiation and RNA processing (Table 2). Overall, chromosome 5
containedmost of the trans-bands, and a single region (80–118Mb)
not only contained the highest number of trans-sQTL in the IFNG/
TNF-stimulated macrophages (66 trans-sQTL), but also was repli-
cated in all the macrophage conditions. About 45 putative splice
factors are physically located in this region of chromosome 5, out
of which 31, 26, 30, 28 were expressed (average FPKM $ 5) in
the nonstimulated, IFNG/TNF-stimulated, infected, and CpG-
stimulated macrophages, respectively. Since all the macrophage
conditions have a large trans-sQTL in this region, 21, 66, 13, and
28 in the nonstimulated, IFNG/TNF-stimulated, CpG-stimulated,
and infected macrophages, respectively, either a differentially
expressed or a polymorphic factor modulates the splicing of the
transcripts with sQTL in this region.
A variation at the Apobec1 locus causes differential C-to-U
mRNA editing
AS and mRNA editing are intricately linked (Lee et al. 1998;
Laurencikiene et al. 2006; Solomon et al. 2013), and the differen-
tially spliced genes, described above, included Apobec1, which
encodes an important editing enzyme. Therefore, we postulated
that the rate of editing might also be variable between the mouse
strains. To test this, we used the RNA-seq data from all the 28
mouse strains to identify single nucleotide variants against the
RefSeq genome (mm9, NCBI build37) using SAMtools/VarScan (Li
2011), followed by a filtering step, which removed all the known
AJ and B6 SNPs (for details, see Methods; for an overview, see
Supplemental Fig. 1). Because editing is relatively conserved within
species (Danecek et al. 2012; Ramaswami et al. 2013), and to reduce
variant artifacts due to sequencing errors, we required a putative
edited nucleotide to be observed in at least seven of the 28 samples
and to be supported by at least five independent RNA-seq reads.
Additionally, since the RI mice are homozygous for almost all
polymorphic AJ and B6 alleles, we excluded variants with more
than two possible alleles. As in the previous sections, the macro-
phage conditions were treated as independent cohorts for these
analyses, resulting in 6716, 3702, 17,898, and 6772 variants, of
which 4176, 3631, 8623, and 3992 were either A-to-G and C-to-T
or the possible reverse-strand T-to-C (Danecek et al. 2012) and
G-to-A variants in the nonstimulated, IFNG/TNF-stimulated, CpG-
stimulated, and Toxoplasma-infected macrophages, respectively.
From all the four macrophage conditions, we observed 13929
nonredundant A-to-G or C-to-T transitions, of which 3886 were
observed in at least two conditions (Supplemental Table 2A), i.e.,
reproduced in 14 independent samples considering the initial filter
Figure 3. mRNA splicing is genetic. (A) The dependence of Apobec3,
Clec7a, and Il3ra splicing on the macrophage genetic background is ge-
netically transmissible and is revealed when the PSI values are averaged
based on the genotype at the relevant splicing QTL (sQTL). (B) Conversely,
the differential splicing of Samhd1 is stimulus-induced and is independent of
the macrophage genetic background. Averaging the Samhd1 PSI values in
the RImice based on the genotype at the Samhd1 suggestive sQTL confirms
that the splicing of Samhd1 is only variable between the stimuli and not the
mouse strains. The AJ allele (AA) is presented as gray bars and the B6 allele
(BB) as black bars (mean 6 SD, [***] P < 0.001, Student’s t-test)
Table 1. Number of significant splicing QTL (sQTL) in the four
macrophage conditions
Stimulation Total significant sQTL cis-sQTL trans-sQTL
Resting 205 68 (57) 137 (53)
IFNG/TNF 285 72 (66) 212 (84)
CpG 395 203 (186) 192 (81)
Toxoplasma 268 56 (45) 212 (76)
Number of cis-sQTL (mapping#10Mb from spliced gene) and trans-sQTL
(mapping >10 Mb from spliced gene) in each stimulation condition is
indicated. The number in parentheses indicates the number of sQTL with
SNPs within 250 bp from the splice site.
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required an edited nucleotide to be present in at least seven sam-
ples in each macrophage condition. Probably due to the pervasive
ADAR editing activity, 61%, 63%, 57%, and 61% of the variants in
the nonstimulated, IFNG/TNF-stimulated, CpG-stimulated, and
Toxoplasma-infected macrophages, respectively, were A-to-G or
T-to-C, withmost genes edited at multiple proximal sites (Danecek
et al. 2012).
Previously, using RNA and DNA sequencing of wild-type and
Apobec1 knockout mice, C-to-U editing was found to occur at the
39 UTR of many transcripts (Rosenberg et al. 2011). Therefore, we
computed the number of edited reads as a percentage of the total
reads overlapping these previously confirmed 39 UTR edited sites
for a subset of genes expressed inmurinemacrophages—B2m,App,
Tmbim6, and Sh3bgrl—in each of the 28 samples. Using the ge-
notype at the Apobec1 sQTL to differentiate the mouse strains, we
observed significantly (Student’s t-test P < 0.05) lower rates of
editing in macrophages from strains carrying the B6 Apobec1 allele
compared to the AJ allele (Fig. 5). Investigation of Apobec1 isoform
usage revealed that regardless of the stimulus, the B6macrophages,
relative to AJ, predominantly express the truncated Apobec1 iso-
form (Fig. 6A,B), suggesting that isoform usage may be the source
of C-to-Tediting variability among themouse strains. However, we
observed that the alternative Apobec1 isoform, which is due to an
alternative acceptor site, did not result in a different protein iso-
form. Additionally, even though not statistically significant, the
QTL modulating Apobec1 transcript expression (eQTL) colocalized
with its sQTL on chromosome 6 (119.9 Mb NCBI mm9), proximal
to its physical location (;122 Mb NCBI mm9). Furthermore,
Apobec1 expressionwas significantly lower (P < 0.05) in the BMDM
from mice carrying the B6 allele at the Apobec1 sQTL, relative to
AJ allele, regardless of the stimulus. Except for the IFNG/TNF-
stimulated BMDM,which had lowerApobec1 expression levels, the
expression level for Apobec1 was not significantly variable among
the macrophage conditions (Fig. 6C). Similar to isoform usage and
expression levels, APOBEC1 editing activity did not significantly
vary with the macrophage microenvironment. An exception to
this was the CpG-stimulated macrophages that, regardless of the
mouse strain, exhibited lower rates of editing, even though these
macrophages did not have the lowest Apobec1 FPKM or PSI values
(Fig. 6B,C). Finally, currently there is no known nonsynonymous
sequence or structural variation in Apobec1 between AJ and the B6
mice. As such, it is not clear if the differential isoform usage or
expression of Apobec1 modulates its editing activity. However, if
differential Apobec1 expression was regulating its editing activity,
thenwe can expect the rate of editing to be lower in the IFNG/TNF-
stimulated BMDM. Yet this is not the case; for example, even
though the average expression of Apobec1 in IFNG/TNF-stimulated
RI macrophages was significantly (Student’s t-test P < 0.05) lower
than in the nonstimulated macrophages, the rate of editing in
these macrophages was not significantly different (Fig. 6D). Nev-
ertheless, if we disregard the genotype at the Apobec1 sQTL, we
found the rate of editing to correlate significantly (P < 0.05) with
the Apobec1 PSI and FPKM, the latter being similar to an observa-
tion previously made in humans (Roberts et al. 2013). Therefore,
throughApobec1 expression or isoformusage or both, a variation at
the Apobec1 locus modulates the variable rate of C-to-U editing,
Figure 4. Linkage analysis of splicing events in RI mice reveals distinct
trans splicing QTL (trans-sQTL). Shown is a representative of a trans-sQTL
enrichment (trans-sQTL hotspot) on chromosome 5 in IFNG/TNF-stimulated
macrophages. The linkage analysis was based on PSI values across 26
recombinant inbred AXB/BXA mice. QTL significance was estimated at
adjusted P < 0.05 after 1000 permutation tests in R/qtl and FDR # 10%.
Each dot represents an individual event, and the circles indicate events
within a 10-Mb window.
Table 2. Large trans-splicing QTL hotspots (trans-bands), their functional enrichment, and putative regulators
Chr Condition
Position
(Mb)
TF
enrichment P-value
Functional enrichment
in trans-bands P-value
Putative candidate
regulator
5 IFNG/TNF- stimulated 104.6 FOXD3 1.45 3 108 RNA splicing 8.90 3 109 Dr1
POU2F1 3.56 3 106 Cellular metabolic process 4.33 3 1013 Hnrpdl
Antigen processing and presentation 9.57 3 106 Hnrpd
2 Resting 21.1 CREBP1 2.31 3 109 Primary metabolic process 6.44 3 1021 Ehmt1
POU5F1 8.22 3 105 Intracellular transport 6.37 3 1015
Cell cycle 2.87 3 108
5 Toxoplasma infected 104.6 FOXD3 4.57 3 104 RNA metabolic processes 0.00007 Dr1
CEBPG 8.13 3 105 Regulation of transcription 1.0 3 1011 Hnrpdl
Hnrpd
13 CpG-stimulated 102.7 POU3F2 2.84 3 106 B-cell proliferation 0.002548 Utp15
Pathway enrichment was assessed using the TRANSFAC database. (Chr) Chromosome; (TF) transcription factor; (Mb) megabase pairs. We used Poisson
distribution to estimate the minimum number of sQTLs needed to map to a single locus before significance is reached (six, seven, six, five) in the
nonstimulated, IFNG/TNF-stimulated, CpG-stimulated, and infected macrophages (respectively). Only the largest trans-sQTL hotspot for each macro-
phage condition is shown here. For additional trans-sQTL hotspots for all conditions, see Supplemental Table 1G.
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although the fact that Apobec1 PSI is significantly mapped to the
genome while the FPKM is not makes isoform usage a strong
candidate.
Previously, C-to-Tediting was observed in human B cells even
though APOBEC1 and its complementation factor (A1CF) tran-
scripts were not detected in these cells (Li et al. 2011), and non
A-to-G (or non T-to-C) transitions observed in different mouse
strains were considered artifacts (Danecek et al. 2012). Therefore,
to further validate and confirm the genetic transmissibility of the
C-to-T editing observed here, we reasoned that if Apobec1 editing
activity is genetic and determined by a variant at its locus, as
suggested above, then in linkage analysis, the rate of editing at
individual sites should map to the Apobec1 locus on chromosome
6 (;122 Mb NCBI build37). This hypothesis is anchored on the
observation that C-to-T transitions do not occur in Apobec1
knockout mice (Rosenberg et al. 2011) and the observation of
C-to-T transitions, in the present study, despite the nondetectable
expression of A1cf (FPKM = 0), both of which suggest a dominant
role for Apobec1 in C-to-T transitions. Therefore, as proof-of-
concept, we used the rate of editing at the previously confirmed
APOBEC1 edited sites (Rosenberg et al. 2011), in the same subset
of genes described above, to identify the genomic loci that mod-
ulate the rate of C-to-U mRNA editing (editing QTL or edQTL) in
murine macrophages, using R/qtl. As expected, the rate of editing
at the previously identified APOBEC1 edited sites (Rosenberg et al.
2011), in genes expressed in macrophages (FPKM$ 100), mapped
significantly to the Apobec1 locus and overlapped perfectly with
the Apobec1 sQTL (Fig. 7; Supplemental Table 2B–E). Next, we ex-
tended this concept to include all the edited sites, described above,
separately for all macrophage conditions. Because we observed in
the preliminary linkage analysis that the rate of editing in genes
with average FPKM < 100 did not significantly map to the Apobec1
sQTL, we introduced a parsimonious filtering step which re-
quired that the edited transcript must be highly expressed (FPKM
$ 100). At FDR# 10%,we observed 63, 119, 138, and 116 edQTL in
the nonstimulated, IFNG/TNF-stimulated, CpG-stimulated, and
infected macrophages, respectively (Supplemental Table 2B–E).
Additionally, because the genotype at Apobec1 sQTL determines
the rate of editing, to identify novel C-to-T edQTL we restricted
the APOBEC1 edited sites to those with edQTL# 10 Mb from the
Apobec1 sQTL. All the variants that significantly mapped within
10 Mb at either side of the Apobec1 sQTL locus (chr6: 109.9–
129.9 Mb) were either C-to-T or G-to-A (Supplemental Table 2B–E).
This observation was true even when we dropped the average
FPKM $ 100 requirement. In the end, from all the macrophage
conditions, we identified a total of 62 C-to-T edited sites that sig-
nificantly mapped to the Apobec1 sQTL, of which 51 (36 non-
redundant) were not reported by Rosenberg et al. (2011) and hence
were considered novel sites (Supplemental Table 2F). Although
not intentionally filtered for, we found that 92% (47/51) of the
novel edited sites were located at the 39UTR, the preferred site for
APOBEC1 editing activity, and all the edited sites were flanked
on both sides by either an adenosine or thymidine nucleotide
(Rosenberg et al. 2011). Using Sanger sequencing, we confirmed
editing of three randomly selected novel sites. In addition, using
the same three novel sites and one previously confirmed site, we
confirmed that the rate of editing is variable in the classical labo-
ratory AJ and B6 mice (Fig. 8). Thus, linkage analysis can be com-
plementary to other methods in identifying novel sites in genes
edited by APOBEC1.
Discussion
AS and mRNA editing, pervasive in eukaryotic transcripts, are
known to contribute to a variety of mammalian phenotypes
(Caceres and Kornblihtt 2002; Dhir and Buratti 2010; Gee et al.
2011; Burns et al. 2013). However, despite the unequivocal
characterization of the cellular factors that mediate these events,
the genetic features that delimit individual differences for these
tightly regulated mRNA biogenesis processes are largely under-
studied. In the current study, we used the fraction of reads sup-
porting constitutive and alternative exons to establish the genetic
basis for AS in murine macrophages. Further, we used the genetic
variation at the Apobec1 locus to demonstrate the variability and
genetic basis of C-to-T editing in classical inbred laboratory mice.
We have ensured reproducibility by performing this study, sepa-
rately, on four different macrophage conditions, each containing
26 RI mouse strains and their two progenitors (a total of 112
samples), and using a stringent filtering step requiring an event to
be observable in at least five (for isoform usage) or seven (for
mRNA editing) mouse strains.
AS has been linked to various human phenotypes (Lee et al.
2012; Braunschweig et al. 2013). In the present study, we detected
significant linkage betweenmurine genetic variants and AS events
for various genes, including Apobec3, Il3ra, Clec7a, and Apobec1,
congruent with previous studies that demonstrated association
between individual AS events and SNPs in the human genome
(Cartegni et al. 2002;Narla et al. 2005; Lee et al. 2012). AS can result
in nonfunctional protein isoforms (LangoAllen et al. 2010), which
may alter cellular physiological states (David et al. 2010; Gao and
Cooper 2013). However, investigating differential isoform usage in
genetically and phenotypically divergent individuals is still un-
common. Therefore, the use of AJ and B6 mice and the corre-
sponding AXB/BXA RI progenies, known to diverge for more than
30 disease phenotypes (Mu et al. 1993), is likely to illuminate the
influence of AS in murine phenotypic differences. For example,
differential splicing of Il3ra, Apobec3, and Clec7a is reported to
contribute to a variety of phenotypes (Jimenez-A et al. 2008; Li
et al. 2012; Stier and Spindler 2012), and we have demonstrated
that isoform usage for these genes is genetically transmissible.
Additionally, the observation that Toxoplasma, which is an oppor-
tunistic pathogen in HIV-infected patients, induces the expression
Figure 5. The rate of APOBEC1-mediated editing is dependent on the
mouse genetic background. We observed strain-specific variable rates of
editing at previously confirmed APOBEC1-edited sites in a set of genes
expressed in macrophages. Using the genotype at the Apobec1 sQTL to
distinguish the RI mice followed by averaging the rate of editing in mice
with the same genotype (;13 for each genotype), we show that the rate
of editing at these previously identified sites varies between macrophages
with the AJ (gray) and B6 (black) genotypes. All the genes, except App,
were reported to have a single APOBEC1 edited site. For App, only one site
supported by themost number of reads was considered (mean6 SD, [***]
P < 0.001, [*] P < 0.05, Student’s t-test).
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of an unstable and nonfunctional isoform of SAMHD1, known
to restrict HIV-1 replication by limiting cellular levels of dNTP
(Welbourn et al. 2012), may have implication in macrophage re-
sponse to Toxoplasma or exacerbate HIV replication in coinfected
HIV patients. This possibility is reinforced by the fact that while
SAMHD1 depletes intracellular dNTPs (Welbourn et al. 2012),
Toxoplasma is dependent on host cellular nucleotides for optimal
growth (Yu et al. 2009). Further experiments are thus needed to
test these hypotheses. Besides genetic variations, epigenetic modi-
fications, such as DNA methylation, are known to regulate mRNA
splicing (Malousi and Kouidou 2012; Gelfman et al. 2013). It is thus
conceivable that by limiting analysis to genetic variants in the
current study, we have excluded splicing eventsmodulated through
epigenetic memory. In addition, due to the limited number of mice
available in this RI line, it is possible that we have overlooked
splicing events that are regulated by complex genetic interactions.
Consequently, a comprehensive study, involving large cohorts and
incorporating epigenetics, may reveal additional loci modulating
splicing events in murine macrophages.
Like AS, mRNA editing is known to contribute to a variety of
mammalian phenotypes (Jiang et al. 2013). However, to the best of
our knowledge, the genetic basis and variability of mRNA editing
in genetically diverse individuals is currently unknown. Here, we
have shown that APOBEC1-editing activity is both variable and
genetic in murine macrophages. While the consensus method for
validating edited nucleotides has been the use of Sanger sequenc-
Figure 6. Apobec1 isoform usage and editing activity is variable betweenmouse strains. (A) Isoform usage for Apobec1 varies between themouse strains,
independent of the stimulus, which is confirmed by averaging the PSI values in the RI mice based on the genotype at the Apobec1 sQTL (B). (C ) Like the
isoform usage, the Apobec1mRNA level is variable between the mouse strains, independent of the stimulus. (D) The rate of editing does not significantly
vary between macrophage conditions, except for CpG-stimulated macrophages, which generally have lower rates of editing. The average PSI or FPKM
values for RI lines having the AJ Apobec1 sQTL allele is represented by the gray bars and B6 allele by the black bars (mean6 SD, [ns] not significant, [***] P <
0.05, Student’s t-test).
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ing of both DNA and RNA, a method that relies solely on RNA-seq
data has recently been published (Ramaswami et al. 2013). We
have applied this method, together with other rigorous filters, to
confirm known edited sites and identify novel sites. Although the
use of linkage analysis to confirm edited sites is novel, it requires
completepenetrance or dominance, preferably related to the editing
enzyme. Editosomes composed of several genetic variants with
small effects may confound linkage analysis, thereby hindering
accurate validation of edited sites. This probably explains the lack of
genetic coherence in the present study forADARediting activity. For
instance, the editing activity of ADAR does not correlate with its
expression (Jacobs et al. 2009; Wahlstedt et al. 2009), but with,
among other factors, AS, self-editing, and sumoylation (Rueter et al.
1999; Desterro et al. 2005). Additionally, ADAR editing activity re-
quires enhancers (Garncarz et al. 2013), which may complicate
linkage analysis. Consistent with this complex regulation of ADAR
editing activity, we did not observe a clear pattern of variability for
the rate of A-to-G editing in themouse strains, which is similar to an
observation made in 15 mouse strains (Danecek et al. 2012), in-
cluding the two progenitors used in the present study. Even though
we observed significant edQTL for some A-to-G and T-to-C transi-
tions, these did not colocalize to the Adar genomic locus (chr3:
89.53–89.55) or any other loci.
The colocalization of Apobec1 sQTL and eQTL proximal to its
physical location has complicated the identification of the mo-
lecular basis for its differential editing activity. Compounding this
further, is the observation that the alternative Apobec1 isoform,
identified here, does not result in an alternative protein isoform.
Even though a previous study reported a correlation between
APOBEC expression and its editing activity in humans (Roberts
et al. 2013), in the present study it appears that either or both
Apobec1 isoformusage and expressionmodulate its editing activity.
We can, however, conclude that a genetic variation at the Apobec1
locus, whichwe place upstreamof both its splicing and expression,
modulates its editing activity. It is worth noting that APOBEC1
editing activity studies in humans and mice have revealed some
broad differences. For example, C-to-T editing occurs in humans
Figure 7. APOBEC1-mediated mRNA editing is genetic. Using linkage
analysis and the rate of editing at previously confirmed sites on the 39 UTR
of B2m (A), App (B), and Tmbim6 (C ) in murine macrophages, we show
that APOBEC1-mediated editing is genetic and linked to the same genetic
marker as the Apobec1 sQTL on chromosome 6. The Apobec1 sQTL is
shown in black, and the edQTL for each gene is indicated in gray. While
significant sQTL were identified at adjusted P < 0.05 after 1000 permu-
tations in R/qtl, we show on the plots the actual adjusted P-values for each
edQTL and the Apobec1 sQTL.
Figure 8. Validation of novel sites and the strain variability of C-to-T
editing. Representative examples of Sanger sequencing chromatograms
for editing of Itgb2, at chr10:77028356 (A); Msn, at chrX:93363499 (B);
and Ctnnb1, at chr9:120869190 (C ) in AJ and B6 macrophages. (D) Also
shown is a previously confirmed edited site in Tmbim6 at chr15:99239051,
which we used, together with the novel sites, to show the variability
(chromatogram height for the nonreference base) of APOBEC1 editing
activity in AJ and B6 macrophages.
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even in the absence of APOBEC1 expression (Li et al. 2011; Roberts
et al. 2013), while in mice the absence of Apobec1 abrogates C-to-T
transitions (Rosenberg et al. 2011). Alsoworth noting is that, while
this previous study (Roberts et al. 2013) investigated APOBEC
editing activity in general, which includes all the differentAPOBEC
gene variants in humans, in the present study, we looked specifi-
cally at edited sites with significant edQTL at the Apobec1 locus. It
may well be that Apobec1 expression determines its editing activity
and that there is a minimum expression threshold that once
reached, i.e., in the IFNG/TNF-stimulated BMDM,maximal editing
activity is achieved. However, we speculate that while the alter-
native splice acceptor site does not alter the protein sequence, it
can alter the mRNA translation efficiency. A detailed investigation
of both Apobec1 mRNA transcription and translation efficiency
may provide further insight into how the different Apobec1 iso-
forms correlate with its editing activity.
Unlike for AICDA, APOBEC3, and ADAR, the biological sig-
nificance for APOBEC1 editing activity is still equivocal. Although
APOBEC1 was initially reported to edit C-to-U in the exon of
Apob, it is now known that it binds mRNA at AU-rich templates
(Navaratnam et al. 1995) and, from the present study and a pre-
vious study (Rosenberg et al. 2011), edits predominantly the
39 UTR. However, the biological relevance of this predominant
39 UTR editing is not clear. However, due to the observation that
both APOBEC1 and miRNA bind the AU-rich templates at the
39UTR and that severalmiRNA-binding seeds overlap the APOBEC1
edited sites (Rosenberg et al. 2011), we can speculate on the im-
portance of 39 UTR editing on mRNA biogenesis. Because the
39 UTR can influence post-transcriptional regulation of gene ex-
pression, by modulating mRNA localization, translation, and sta-
bility (Winter et al. 2008), one hypothesis is that 39 UTR editing is
biologically designed to selectively regulate these processes. To this
end, althoughAPOBEC1has been shown tomodulate intracellular
viral replicationmostly through the editing of viral DNA/RNA, it is
possible that 39 UTR editing of host mRNA indirectly affects viral
pathogenesis. Particularly since some viruses, such as human cy-
tomegalovirus, produce miRNA that target specific isoforms of
host mRNAs at the 39 UTR, thereby modulating various immune
processes such as antigen processing and presentation (Kim et al.
2011), editing of these viral miRNA binding sites might inhibit
viral miRNA binding. Additionally, some of the edited genes, in-
cluding B2m and Itgb2, are known to function in immune processes.
As such, the stability, localization, and translation efficiency of these
transcripts may influence immune processes (Cogen and Moore
2009; Yee and Hamerman 2013). Collectively, the lowering of
plasma LDL levels by the ectopic expression of Apobec1 (Teng et al.
1994;Greeve et al. 1996); the localization of plasma cholesterol level
QTL to the Apobec1 locus (Mehrabian et al. 2005); and the obser-
vation that App, an APOBEC1-edited gene, regulates insulin secre-
tion from pancreatic cells (Tu et al. 2012) suggests that APOBEC1
may be the causative gene for common physiological traits such as
atherosclerosis and diet induced obesity.
Methods
RNA sequencing
BMDMswere plated in six-well plates (33 106 cells/well) overnight
before stimulation or infection. For stimulation, IFNG (100 ng/mL)/
TNF (100 ng/mL) or CpG (50 ng/mL) was added to each well for
18 h; while for the infected sample, a type II strain of T. gondii (Pru)
was added to the confluent BMDM at an MOI of 1.3 for 8 h. Total
RNA was isolated (Qiagen RNeasy Plus kit), and the integrity, size,
and concentration of the RNA were checked (Agilent 2100 Bio-
analyzer). The mRNA was then purified by polyA-tail enrichment
(Dynabeads mRNA purification kit; Invitrogen), fragmented into
200–400 bp, and reverse transcribed into cDNA followed by se-
quencing adapter ligation at each end. Libraries were barcoded,
multiplexed into four samples per sequencing lane in the Illumina
HiSeq 2000, and sequenced from both ends (except for IFNG/TNF-
stimulated samples, which were subjected to single-end sequenc-
ing), resulting in 40-bp reads after discarding the barcodes. Our
preliminary RNA-seq experiments with infected BMDMs have
shown that with four samples per lane, we still obtain enough read
coverage for reliable gene expression analysis.
Alignment of reads to the genome
Reads were initially mapped to the mouse reference genome
(mm9, NCBI build 37) and the Toxoplasma (ME49 v8.0) genome
using Bowtie (2.0.2) (Langmead et al. 2009) and TopHat (v2.0.4)
(Trapnell et al. 2009) in the n-alignment mode. Because the ref-
erence genome to which we mapped the RNA-seq reads is based
on the C57BL/6J genomic sequence, and because of the known
polymorphisms between the AJ and C57BL/6J, we suspected that
sequence variations might introduce read-mapping biases. To
mitigate this potential bias toward the reference allele, we created
a copy of the mouse reference genome in which all the known
single nucleotide polymorphisms (SNPs) between AJ and B6 (ftp://
ftp-mouse.sanger.ac.uk/current_snps/) were converted to a third
(neutral) nucleotide that is different from both the reference and
AJ allele (Degner et al. 2009). However, this did not substantially
change the average proportion of uniquely mapped reads in all the
samples. In the end we used the mapping data generated from the
synthetic genome.
Isoform usage
PSI values were calculated in MISO v.0.4.6 (Katz et al. 2010) in the
single-end mode using the splicing event annotation files for
major classes of alternative RNA processing downloaded from the
MISO web page (http://genes.mit.edu/burgelab/miso/), based on
the mm9 (NCBI buld37) genome assembly (parameters:–read-len
40, –overhang 8). PSI values were obtained in each sample for each
macrophage condition. The differentmacrophage conditionswere
processed separately. BF was calculated in MISO for each splicing
event and sample relative to the B6 sample in the corresponding
macrophage condition; i.e., to get differential isoform usage of
gene A in the nonstimulated condition, we obtained the BF for A
in each of the 27 samples relative to the B6 sample in the non-
stimulated macrophages. To estimate stimulus specific isoform us-
age,we calculated the BF for each event in the first condition relative
to the corresponding sample in the second condition, for all the
possible pairwise macrophage conditions; i.e., to measure differ-
ential isoform usage in B6 for the nonstimulated versus infected
samples, we calculated the BF for gene A in B6 in the nonstimulated
macrophages relative to gene A in B6 in the infected macrophages.
Finally, we used custom Perl scripts to generate summary tables at
95% CI width. Differences between samples were deemed signifi-
cant at |delta PSI|$ 0.2 between conditions, and BF $ 5.
Identification of edited transcripts
To identify edited mRNA, we processed the four macrophage
conditions separately and followed a sequential procedure, which
involved first retrieving sequence variation among RNA-seq reads
using SAMtools 0.1.18 (r982:295) (Li et al. 2009) mpileup function
across all strains, with parameters –f and –B using the reference
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C57BL/6J genome (mm9). The resulting mpileup files were post-
processed using VarScan v2.2.11 (Koboldt et al. 2012) with the fol-
lowing parameters: mpileup2snp –min-coverage 5, –min-reads2
5, –min-avg-qual 15, –min-var-freq 0.01, –P-value 1, –variants 1.
Only variants called in at least seven strains, called heterozygous in
at least seven independent strains, andwith aminor allele frequency
of at least 10% across all strains, were retained. We used custom Perl
scripts to filter the resulting positions against known sequence varia-
tion between C57BL/6J and A/J strains (ftp://ftp-mouse.sanger.ac.uk/
current_snps/) and annotated against RefSeq sequence using
BEDTools v.2.16.1 (Quinlan and Hall 2010). Finally, we used link-
age analysis to confirm the novel edited sites, by treating the rate
of editing as a quantitative trait and including for further analysis
only genes that mapped to the of Apobec1 sQTL. This was validated
by the location of editing QTLs for known APOBEC1 edited sites
(Rosenberg et al. 2011)
Quantitative trait locus (QTL) mapping
To map QTLs, we obtained 934 informative AXB/BXA genetic
markers from http://www.genenetwork.org. We then used the PSI
values or the rate of editing in the AXB/BXA mice to perform ge-
nome-wide scans with genotype as main effect in R/qtl. Adjusted
P-values at each QTL were calculated using 1000 permutations of
the phenotype data as previously described (Churchill and Doerge
1994). Next, we calculated the corresponding qvalues for the ge-
nome-wide adjusted P-values in the qvalue package using the
bootstrap method (Storey and Tibshirani 2003). QTLs were con-
sidered significant at FDR # 0.1. To determine if the number of
splicing events mapping in trans to a single genomic window, e.g.,
the chromosome 5 locus in the IFNG/TNF-stimulatedmacrophages,
can be characterized as trans-sQTL hotspot, we used the Poisson
distribution to compute the number of trans-sQTL that need to
colocalize in a 10-Mb genomic window to constitute a trans-band
and found six, seven, six, and five for the nonstimulated, IFNG/
TNF-stimulated, CpG-stimulated, and infected macrophages, re-
spectively. To do this, we divided the mouse mapped genome
length, excluding the Y chromosome (since all the mice used here
were female), into equal 10-Mb windows (258 windows). For each
macrophage condition, using the observed number of trans-sQTL,
we then calculated the number of trans-sQTLs that have to map to
the same 10-Mb window to reach significance. First we calculated,
for each condition, a Bonferroni-corrected P-value by dividing 0.05
(the genome-wide adjusted P < 0.05 used to identify significant
sQTL) by the number of possible windows. We then used the Pois-
son distribution to calculate the minimum number of events that
have to map to a single window to reach significance, using this
Bonferroni-corrected P-value.
Sanger sequencing
To validate the novel C-to-T edited sites, we randomly selected
three nonredundant novel edited sites, in three different genes,
together with one previously confirmed edited site for Sanger se-
quencing. Wemade cDNA from the relevant mRNA samples using
oligo-dT. Next, using primers designed to anneal at least 100 bp
from either side of the edited nucleotide, we amplified the edited
site using polymerase chain reaction (PCR). The PCRproductswere
purified (QIAquick PCR Purification kit, Qiagen) and commercially
sequenced (http://www.genewiz.com).
Data access
The RNA-seq data have been submitted to the NCBI Gene Ex-
pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) un-
der accession number GSE47540.
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